Filing Details
- Accession Number:
- 0001127602-21-019710
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-11 16:07:21
- Reporting Period:
- 2021-06-10
- Accepted Time:
- 2021-06-11 16:07:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1651281 | Lukas Scheibler | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Chief Innovation Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-10 | 3,417 | $60.00 | 26,651 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 778 shares from 04/30/21 ESPP Purchase.
- This is a scheduled sale from 10B5-1 trading plan.
Billionaire Hedge Funds
